CRTC2 Promotes AML Progression and Mediates Mitochondrially‐Driven Venetoclax Resistance

癌症研究 基因敲除 髓系白血病 医学 祖细胞 下调和上调 细胞凋亡 骨髓 髓样 疾病 细胞 恶性肿瘤 白血病 生物标志物 抗药性 细胞生长 癌症 染色质免疫沉淀 威尼斯人 肿瘤进展 电池类型 间质细胞 生物
作者
Xiaomei Liang,Yilu Zheng,Bangxue Jiang,Yu‐Ling Huang,Jing Tang,Haimei Deng,Chenxing Zhang,Minyi Zhao,Dongjun Lin
出处
期刊:The FASEB Journal [Wiley]
卷期号:39 (23): e71316-e71316
标识
DOI:10.1096/fj.202503054r
摘要

Acute myeloid leukemia (AML) is a hematologic malignancy characterized by the malignant proliferation of myeloid progenitor cells. Although the introduction of the B-cell lymphoma-2 (BCL-2) inhibitor Venetoclax (VEN) has significantly improved patient outcomes and established it as a first-line treatment, high rates of drug resistance and relapse remain major clinical challenges. We integrated RUNX3 chromatin immunoprecipitation sequencing (ChIP-seq) data with the GAPIA2 database to identify CRTC2 as a key candidate gene. Subsequently, we employed qRT-PCR to compare CRTC2 expression levels between donors and AML patients. The role of CRTC2 in apoptosis was further validated through knockdown and overexpression experiments in various cell lines. To investigate the impact of CRTC2 on AML progression, we established a cell line-derived xenograft (CDX) model. The proportion of human CD45-positive (hCD45+) cells in the bone marrow and liver was assessed, and histological examination was conducted using HE staining, along with peripheral blood smear analysis. In addressing VEN resistance, we analyzed CRTC2 expression patterns in clinical samples and explored the synergistic therapeutic effect of a CRTC2 inhibitor in combination with VEN. To further elucidate the underlying molecular mechanisms, we performed mitochondrial function assays and analyzed mitochondrial translation-related proteins. Clinical analyses have demonstrated that elevated expression levels of CRTC2, a downstream target of RUNX3, are significantly correlated with poor prognosis in patients with AML. Functional experiments have shown that CRTC2 plays a role in disease progression by modulating apoptosis in AML cells. The knockdown of CRTC2 was observed to delay disease progression in CDX mouse models. Additional investigations revealed a positive correlation between CRTC2 expression and resistance to VEN in AML cells, with CRTC2 inhibition synergistically enhancing VEN's cytotoxic effects. Mechanistic studies suggest that increased mitochondrial activity contributes to VEN resistance, thereby identifying a potential molecular target for overcoming drug resistance. CRTC2 is a key regulator in AML, with high expression levels promoting disease progression and resistance to VEN. Inhibiting CRTC2 reduces mitochondrial translation and energy reserves, increasing AML cell sensitivity to VEN. These results highlight CRTC2 as a promising therapeutic target and suggest a new strategy to overcome VEN resistance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
123发布了新的文献求助10
1秒前
abc发布了新的文献求助10
1秒前
3秒前
leilei发布了新的文献求助10
3秒前
向浏岚完成签到,获得积分10
3秒前
開訫亿百倍完成签到 ,获得积分10
3秒前
null完成签到,获得积分0
4秒前
Liangccg发布了新的文献求助10
4秒前
科目三的应助被周周采纳,获得200
4秒前
科研通AI65的应助被StudyJW采纳,获得10
4秒前
123完成签到 ,获得积分10
4秒前
加点研完成签到,获得积分10
4秒前
柚子完成签到 ,获得积分20
6秒前
研友_VZG7GZ的应助被123采纳,获得10
6秒前
沉默完成签到,获得积分10
6秒前
李健的小迷弟的应助被子夜歌采纳,获得10
8秒前
8秒前
10秒前
hehe发布了新的文献求助20
12秒前
liuchang完成签到 ,获得积分10
14秒前
咩咩小博士完成签到 ,获得积分10
14秒前
惜梦完成签到 ,获得积分10
15秒前
abc发布了新的文献求助10
15秒前
小情绪发布了新的文献求助10
15秒前
18秒前
齐一诺完成签到 ,获得积分10
19秒前
kililolo完成签到,获得积分10
19秒前
lqx完成签到,获得积分10
20秒前
百里完成签到 ,获得积分20
21秒前
21秒前
无辜飞风完成签到,获得积分10
22秒前
负责以山完成签到 ,获得积分10
24秒前
科研通AI2S的应助被风吹麦浪采纳,获得10
24秒前
王培德发布了新的文献求助10
24秒前
英姑的应助被风吹麦浪采纳,获得10
24秒前
科研通AI6.2的应助被风吹麦浪采纳,获得10
24秒前
Husile发布了新的文献求助10
26秒前
刻苦的媚颜完成签到 ,获得积分10
27秒前
29秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186734
求助须知:如何正确求助?哪些是违规求助? 9575007
关于积分的说明 21839114
捐赠科研通 7784289
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611